{
    "organizations": [],
    "uuid": "b204cf5a87f70525cb1afcdc98f1aa0752ebdc63",
    "author": "",
    "url": "https://www.reuters.com/article/brief-lilly-receives-additional-fda-appr/brief-lilly-receives-additional-fda-approval-for-verzeniotm-as-initial-treatment-for-advanced-breast-cancer-idUSASB0C7JH",
    "ord_in_thread": 0,
    "title": "BRIEF-Lilly Receives Additional FDA Approval For Verzeniotm, As Initial Treatment For Advanced Breast Cancer",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": " 32 PM / Updated 6 minutes ago BRIEF-Lilly Receives Additional FDA Approval For Verzeniotm, As Initial Treatment For Advanced Breast Cancer Reuters Staff Feb 26 (Reuters) - Eli Lilly And Co: * LILLY RECEIVES ADDITIONAL FDA APPROVAL FOR VERZENIOTM (ABEMACICLIB), AS INITIAL TREATMENT FOR ADVANCED BREAST CANCER * ELI LILLY AND CO - ‍NEW INDICATION BASED ON MONARCH 3 TRIAL CAN HELP MORE WOMEN LIVING WITH HR+, HER2- ADVANCED BREAST CANCER​ * ELI LILLY - ‍RECOMMENDED DOSE OF VERZENIO IN COMBINATION WITH AI IS 150 MG ORALLY TWICE DAILY, CONTINUED UNTIL DISEASE PROGRESSION/ UNACCEPTABLE TOXICITY​ * ELI LILLY AND CO - ‍VERZENIO IS AVAILABLE IN 4 TABLET STRENGTHS (200 MG, 150 MG, 100 MG, AND 50 MG)​ Source text for Eikon: Further company coverage:",
    "published": "2018-02-26T23:31:00.000+02:00",
    "crawled": "2018-02-26T23:43:27.001+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "pm",
        "updated",
        "minute",
        "ago",
        "receives",
        "additional",
        "fda",
        "approval",
        "verzeniotm",
        "initial",
        "treatment",
        "advanced",
        "breast",
        "cancer",
        "reuters",
        "staff",
        "feb",
        "reuters",
        "eli",
        "lilly",
        "co",
        "lilly",
        "receives",
        "additional",
        "fda",
        "approval",
        "verzeniotm",
        "abemaciclib",
        "initial",
        "treatment",
        "advanced",
        "breast",
        "cancer",
        "eli",
        "lilly",
        "co",
        "indication",
        "based",
        "monarch",
        "trial",
        "help",
        "woman",
        "living",
        "advanced",
        "breast",
        "eli",
        "lilly",
        "dose",
        "verzenio",
        "combination",
        "ai",
        "mg",
        "orally",
        "twice",
        "daily",
        "continued",
        "disease",
        "unacceptable",
        "eli",
        "lilly",
        "co",
        "available",
        "tablet",
        "strength",
        "mg",
        "mg",
        "mg",
        "mg",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}